This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kuntz, K. M. Articles by Weinstein, M. C. Search for Related Content PubMed PubMed Citation Articles by Kuntz, K. M. Articles by Weinstein, M. C. Social Bookmarking                   What's this?

Life Expectancy Biases in Clinical Decision Modeling

Milton C. Weinstein, PhD

Clinical decision models often rely upon survival models predicated on disease-specific hazard functions combined with baseline hazard functions obtained from standard life tables. Two biases may arise in such a modeling process. First, life expectancy estimates may be biased even if estimates of survival probabilities are unbiased (misestimation bias). In sim ulation studies, the authors discovered that the magnitude of misestimation bias is larger as life expectancy increases, sample size decreases, and censoring percentage increases. In the context of a simple decision analysis, they found that imbalances in the sample sizes for the data used to estimate the parameters among different strategies resulted in non- optimal decisions in the long run. The second bias stems from misspecification of the survival model itself (misspecification bias). Using a simple cost-effectiveness model, the authors found that life expectancies and incremental cost-effectiveness ratios differed depending on whether an excess-mortality or a proportional-hazards model was specified. In addition, a predictable pattern was observed for these two survival models when extrapolated to other age and gender groups. Key words: Markov models; Markov-cycle tree; decision making; excess-mortality model; proportional-hazards model; life expectancy. (Med Decis Making 1995;15:158-169)

Medical Decision Making, Vol. 15, No. 2, 158-169 (1995)
DOI: 10.1177/0272989X9501500209


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. Benbassat and R. Baumal The time horizons of formal decision analyses QJM, June 1, 2007; 100(6): 383 - 388. [Abstract] [Full Text] [PDF]

				P. S. Chan, B. K. Nallamothu, H. S. Gurm, R. A. Hayward, and S. Vijan Incremental Benefit and Cost-Effectiveness of High-Dose Statin Therapy in High-Risk Patients With Coronary Artery Disease Circulation, May 8, 2007; 115(18): 2398 - 2409. [Abstract] [Full Text] [PDF]

				S. K. Plevritis Decision Analysis and Simulation Modeling for Evaluating Diagnostic Tests on the Basis of Patient Outcomes Am. J. Roentgenol., September 1, 2005; 185(3): 581 - 590. [Full Text] [PDF]

				A. B. Rosen, M. B. Hamel, M. C. Weinstein, D. M. Cutler, A. M. Fendrick, and S. Vijan Cost-Effectiveness of Full Medicare Coverage of Angiotensin-Converting Enzyme Inhibitors for Beneficiaries with Diabetes Ann Intern Med, July 19, 2005; 143(2): 89 - 99. [Abstract] [Full Text] [PDF]

				N. F. Col, G. Weber, A. Stiggelbout, J. Chuo, R. D'Agostino, and P. Corso Short-term Menopausal Hormone Therapy for Symptom Relief: An Updated Decision Model Arch Intern Med, August 9, 2004; 164(15): 1634 - 1640. [Abstract] [Full Text] [PDF]

				K. M. Kuntz and S. J. Goldie Assessing the Sensitivity of Decision-Analytic Results to Unobserved Markers of Risk: Defining the Effects of Heterogeneity Bias Med Decis Making, June 1, 2002; 22(3): 218 - 227. [Abstract] [PDF]

				N. J.O. Birkmeyer Simulation techniques to support prosthetic valve choice in aortic valve replacement: Reply Ann. Thorac. Surg., November 1, 2001; 72(5): 1795 - 1796. [Full Text] [PDF]

				D. A. Ganz, K. M. Kuntz, G. A. Jacobson, and J. Avorn Cost-Effectiveness of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor Therapy in Older Patients with Myocardial Infarction Ann Intern Med, May 16, 2000; 132(10): 780 - 787. [Abstract] [Full Text] [PDF]

				R. R. Holland, C. A. Ellis, B. M. Geller, D. A. Plante, and R. H. Secker-Walker Life Expectancy Estimation with Breast Cancer: Bias of the Declining Exponential Function and an Alternative to Its Use Med Decis Making, October 1, 1999; 19(4): 385 - 393. [Abstract] [PDF]

				N. F. Col, M. H. Eckman, R. H. Karas, S. G. Pauker, R. J. Goldberg, E. M. Ross, R. K. Orr, and J. B. Wong Patient-Specific Decisions About Hormone Replacement Therapy in Postmenopausal Women JAMA, April 9, 1997; 277(14): 1140 - 1147. [Abstract] [PDF]